ENVESTNET ASSET MANAGEMENT INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$471,785
-6.1%
19,062
+7.4%
0.00%
Q2 2023$502,623
+38.9%
17,748
+12.7%
0.00%
Q1 2023$361,732
-12.9%
15,748
+6.4%
0.00%
Q4 2022$415,444
+1.1%
14,795
+1.9%
0.00%
Q3 2022$411,000
+74.9%
14,517
+37.0%
0.00%
Q2 2022$235,000
+2.2%
10,595
+34.2%
0.00%
Q1 2022$230,000
+9.0%
7,895
+72.6%
0.00%
Q3 2021$211,000
-37.8%
4,573
-25.6%
0.00%
Q2 2021$339,000
+64.6%
6,146
+54.1%
0.00%
Q1 2021$206,000
-13.4%
3,989
-10.2%
0.00%
Q2 2020$238,000
-2.5%
4,441
-13.1%
0.00%
Q4 2019$244,000
+960.9%
5,109
+1751.1%
0.00%
Q2 2018$23,000
+9.5%
276
+5.3%
0.00%
Q1 2018$21,000
+75.0%
262
+23.6%
0.00%
Q4 2017$12,0000.0%212
+14.6%
0.00%
Q3 2017$12,000
+100.0%
185
+54.2%
0.00%
Q2 2017$6,000
+20.0%
120
+23.7%
0.00%
Q1 2017$5,000
+400.0%
97
+361.9%
0.00%
Q4 2016$1,000
-99.1%
21
-99.2%
0.00%
Q2 2016$106,000
-5.4%
2,542
-8.2%
0.00%
Q1 2016$112,000
-17.6%
2,769
+32.6%
0.00%
-100.0%
Q4 2015$136,000
-0.7%
2,089
+7.3%
0.00%0.0%
Q3 2015$137,000
-31.8%
1,947
+7.9%
0.00%0.0%
Q2 2015$201,0001,8050.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders